Fibrinogen and Bleeding After Cardiac Surgery

Trial Profile

Fibrinogen and Bleeding After Cardiac Surgery

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Nov 2015

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Surgical blood loss
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Fibro-3
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Nov 2015 New trial record
    • 17 Nov 2015 Primary endpoint has not been met. (Blood loss first 12 postoperative hours), as per results published in the British Journal of Anaesthesia.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top